ÂÜÀòÂÒÂ×

Kim Binderup serves as the Chief Consumer Health Officer at Vectura Fertin Pharma since 2022, leading the Consumer Health business in an organization known for its proprietary portfolios in Consumer Health and Inhalable Therapeutics. Kim also holds the position of Vice President Consumer- & Digital Health at Philip Morris International and is a Board Member at Beo Therapeutics AG and UAS Laboratories. Previous experience includes serving as Global Vice President of Innovation at DSM for the Human Nutrition & Health sector, and various leadership roles at Chr. Hansen Holding A/S, focusing on innovation and strategic sourcing in Natural Colors and Human Health. Kim's early career includes management consulting at Boston Consulting Group and scientific research roles at DSM Anti-Infectives and Universitè de Lille. Kim holds a PhD in Biochemistry from Michigan State University and an Executive MBA from London Business School.